- Home
- LSTA vs BEAT Comparison
LSTA vs BEAT Comparison
Compare LSTA & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSTA | BEAT |
|---|---|---|
| Founded | 1980 | 2015 |
| Country | United States | United States |
| Employees | N/A | 17 |
| Industry | Misc Health and Biotechnology Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 31.6M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | LSTA | BEAT |
|---|---|---|
| Price | $1.67 | $0.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $15.00 | $5.63 |
| AVG Volume (30 Days) | 65.8K | ★ 660.6K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,283,868.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 56.90 | N/A |
| 52 Week Low | $1.81 | $0.51 |
| 52 Week High | $5.07 | $4.00 |
Technical Indicators
Market Signals| Indicator | LSTA | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 19.52 | 33.62 |
| Support Level | N/A | N/A |
| Resistance Level | $2.19 | $0.79 |
| Average True Range (ATR) | 0.22 | 0.06 |
| MACD | -0.18 | -0.00 |
| Stochastic Oscillator | 1.40 | 4.14 |
Price Performance
Historical ComparisonAbout LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.